↓ Skip to main content

American Association for Cancer Research

Article Metrics

Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors

Overview of attention for article published in Cancer Immunology Research, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
twitter
22 tweeters

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
71 Mendeley
citeulike
1 CiteULike
Title
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
Published in
Cancer Immunology Research, November 2018
DOI 10.1158/2326-6066.cir-18-0245
Pubmed ID
Authors

Emma C. de Moel, Elisa A. Rozeman, Ellen H. Kapiteijn, Els M.E. Verdegaal, Annette Grummels, Jaap A. Bakker, Tom W.J. Huizinga, John B. Haanen, René E.M. Toes, Diane van der Woude

Twitter Demographics

The data shown below were collected from the profiles of 22 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 71 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 21%
Student > Ph. D. Student 10 14%
Student > Doctoral Student 7 10%
Other 7 10%
Student > Master 6 8%
Other 12 17%
Unknown 14 20%
Readers by discipline Count As %
Medicine and Dentistry 27 38%
Biochemistry, Genetics and Molecular Biology 9 13%
Immunology and Microbiology 8 11%
Neuroscience 2 3%
Agricultural and Biological Sciences 1 1%
Other 2 3%
Unknown 22 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2021.
All research outputs
#1,302,455
of 19,539,469 outputs
Outputs from Cancer Immunology Research
#124
of 1,191 outputs
Outputs of similar age
#41,797
of 411,706 outputs
Outputs of similar age from Cancer Immunology Research
#5
of 37 outputs
Altmetric has tracked 19,539,469 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,191 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 411,706 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.